94 related articles for article (PubMed ID: 15610403)
1. Orofacial and gastrointestinal hyperplasia and neoplasia in smad4+/- and elf+/-/smad4+/- mutant mice.
Redman RS; Katuri V; Tang Y; Dillner A; Mishra B; Mishra L
J Oral Pathol Med; 2005 Jan; 34(1):23-9. PubMed ID: 15610403
[TBL] [Abstract][Full Text] [Related]
2. Squamous cell carcinoma and mammary abscess formation through squamous metaplasia in Smad4/Dpc4 conditional knockout mice.
Li W; Qiao W; Chen L; Xu X; Yang X; Li D; Li C; Brodie SG; Meguid MM; Hennighausen L; Deng CX
Development; 2003 Dec; 130(24):6143-53. PubMed ID: 14597578
[TBL] [Abstract][Full Text] [Related]
3. Loss of cooperative function of transforming growth factor-beta signaling proteins, smad3 with embryonic liver fodrin, a beta-spectrin, in primary biliary cirrhosis.
Mishra B; Tang Y; Katuri V; Fleury T; Said AH; Rashid A; Jogunoori W; Mishra L
Liver Int; 2004 Dec; 24(6):637-45. PubMed ID: 15566516
[TBL] [Abstract][Full Text] [Related]
4. Hair follicle defects and squamous cell carcinoma formation in Smad4 conditional knockout mouse skin.
Qiao W; Li AG; Owens P; Xu X; Wang XJ; Deng CX
Oncogene; 2006 Jan; 25(2):207-17. PubMed ID: 16170355
[TBL] [Abstract][Full Text] [Related]
5. Haploid loss of the tumor suppressor Smad4/Dpc4 initiates gastric polyposis and cancer in mice.
Xu X; Brodie SG; Yang X; Im YH; Parks WT; Chen L; Zhou YX; Weinstein M; Kim SJ; Deng CX
Oncogene; 2000 Apr; 19(15):1868-74. PubMed ID: 10773876
[TBL] [Abstract][Full Text] [Related]
6. Gastric and duodenal polyps in Smad4 (Dpc4) knockout mice.
Takaku K; Miyoshi H; Matsunaga A; Oshima M; Sasaki N; Taketo MM
Cancer Res; 1999 Dec; 59(24):6113-7. PubMed ID: 10626800
[TBL] [Abstract][Full Text] [Related]
7. Differences in Smad4 expression in human papillomavirus type 16-positive and human papillomavirus type 16-negative head and neck squamous cell carcinoma.
Báez A; Cantor A; Fonseca S; Marcos-Martinez M; Mathews LA; Muro-Cacho CA; Muñoz-Antonia T
Clin Cancer Res; 2005 May; 11(9):3191-7. PubMed ID: 15867212
[TBL] [Abstract][Full Text] [Related]
8. [Gastrointestinal tumorigenesis in Smad4 mutant mice].
Takaku K; Taketo M
Tanpakushitsu Kakusan Koso; 2001 Feb; 46(2):117-23. PubMed ID: 11211785
[No Abstract] [Full Text] [Related]
9. Gastrointestinal tumorigenesis in Smad4 (Dpc4) mutant mice.
Taketo MM; Takaku K
Hum Cell; 2000 Sep; 13(3):85-95. PubMed ID: 11197776
[TBL] [Abstract][Full Text] [Related]
10. Smad4 is required for the normal organization of the cartilage growth plate.
Zhang J; Tan X; Li W; Wang Y; Wang J; Cheng X; Yang X
Dev Biol; 2005 Aug; 284(2):311-22. PubMed ID: 16023633
[TBL] [Abstract][Full Text] [Related]
11. Serrated adenomas and mixed polyposis caused by a splice acceptor deletion in the mouse Smad4 gene.
Hohenstein P; Molenaar L; Elsinga J; Morreau H; van der Klift H; Struijk A; Jagmohan-Changur S; Smits R; van Kranen H; van Ommen GJ; Cornelisse C; Devilee P; Fodde R
Genes Chromosomes Cancer; 2003 Mar; 36(3):273-82. PubMed ID: 12557227
[TBL] [Abstract][Full Text] [Related]
12. [Aberrations of Smad genes in human digestive tract cancers].
Hagiwara K
Tanpakushitsu Kakusan Koso; 2001 Feb; 46(2):124-9. PubMed ID: 11211786
[No Abstract] [Full Text] [Related]
13. Smad4 deficiency in cervical carcinoma cells.
Baldus SE; Schwarz E; Lohrey C; Zapatka M; Landsberg S; Hahn SA; Schmidt D; Dienes HP; Schmiegel WH; Schwarte-Waldhoff I
Oncogene; 2005 Jan; 24(5):810-9. PubMed ID: 15531914
[TBL] [Abstract][Full Text] [Related]
14. Critical interactions between TGF-beta signaling/ELF, and E-cadherin/beta-catenin mediated tumor suppression.
Katuri V; Tang Y; Li C; Jogunoori W; Deng CX; Rashid A; Sidawy AN; Evans S; Reddy EP; Mishra B; Mishra L
Oncogene; 2006 Mar; 25(13):1871-86. PubMed ID: 16288220
[TBL] [Abstract][Full Text] [Related]
15. Kaposi's sarcoma-associated herpesvirus viral IFN regulatory factor 1 inhibits transforming growth factor-beta signaling.
Seo T; Park J; Choe J
Cancer Res; 2005 Mar; 65(5):1738-47. PubMed ID: 15753369
[TBL] [Abstract][Full Text] [Related]
16. TGFbeta signaling and cancer.
Hata A
Exp Cell Res; 2001 Mar; 264(1):111-6. PubMed ID: 11237527
[No Abstract] [Full Text] [Related]
17. Transforming growth factor-beta suppresses nonmetastatic colon cancer through Smad4 and adaptor protein ELF at an early stage of tumorigenesis.
Tang Y; Katuri V; Srinivasan R; Fogt F; Redman R; Anand G; Said A; Fishbein T; Zasloff M; Reddy EP; Mishra B; Mishra L
Cancer Res; 2005 May; 65(10):4228-37. PubMed ID: 15899814
[TBL] [Abstract][Full Text] [Related]
18. Smad4 dependency defines two classes of transforming growth factor {beta} (TGF-{beta}) target genes and distinguishes TGF-{beta}-induced epithelial-mesenchymal transition from its antiproliferative and migratory responses.
Levy L; Hill CS
Mol Cell Biol; 2005 Sep; 25(18):8108-25. PubMed ID: 16135802
[TBL] [Abstract][Full Text] [Related]
19. Smad4 signalling in T cells is required for suppression of gastrointestinal cancer.
Kim BG; Li C; Qiao W; Mamura M; Kasprzak B; Anver M; Wolfraim L; Hong S; Mushinski E; Potter M; Kim SJ; Fu XY; Deng C; Letterio JJ
Nature; 2006 Jun; 441(7096):1015-9. PubMed ID: 16791201
[TBL] [Abstract][Full Text] [Related]
20. Smad4 and ERK2 stimulated by transforming growth factor beta1 in rhabdomyosarcoma.
Guo H; Zhang HY; Wang SL; Ye L; Yang GH; Bu H
Chin Med J (Engl); 2007 Mar; 120(6):515-21. PubMed ID: 17439748
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
